tiprankstipranks
Trending News
More News >
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
US Market

Zelira Therapeutics (ZLDAF) Technical Analysis

Compare
17 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
0Neutral
8Bearish
Technical Analysis Consensus
Neutral
0Bullish
0Neutral
0Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Zelira Therapeutics’s (ZLDAF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Zelira Therapeutics is a Sell.
Zelira Therapeutics’s (ZLDAF) 20-Day exponential moving average is 0.30, while Zelira Therapeutics’s (ZLDAF) share price is $0.3, making it a Sell.
Zelira Therapeutics’s (ZLDAF) 50-Day exponential moving average is 0.32, while Zelira Therapeutics’s (ZLDAF) share price is $0.3, making it a Sell.

Zelira Therapeutics (ZLDAF) Pivot Points

Apr 07, 2025, 10:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.30
0.30
0.30
0.30
0.30
0.30
0.30
Fibonacci
0.30
0.30
0.30
0.30
0.30
0.30
0.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zelira Therapeutics (ZLDAF) Moving Averages

Apr 07, 2025, 10:52 AM
Period
Simple
Exponential
MA5
0.30Buy
0.30Buy
MA10
0.30Sell
0.30Buy
MA20
0.30Buy
0.30Sell
MA50
0.31Sell
0.32Sell
MA100
0.36Sell
0.35Sell
MA200
0.40Sell
0.38Sell
Zelira Therapeutics’s (ZLDAF) 10-Day exponential moving average is 0.30, while Zelira Therapeutics’s (ZLDAF) share price is $0.3, making it a Buy.
Zelira Therapeutics’s (ZLDAF) 100-Day exponential moving average is 0.35, while Zelira Therapeutics’s (ZLDAF) share price is $0.3, making it a Sell.
Zelira Therapeutics’s (ZLDAF) stock price is $0.3 and Zelira Therapeutics’s (ZLDAF) 50-day simple moving average is 0.31, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.3 and Zelira Therapeutics’s (ZLDAF) 100-day simple moving average is 0.36, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.3 and Zelira Therapeutics’s (ZLDAF) 200-day simple moving average is 0.40, creating a Sell signal.

Zelira Therapeutics (ZLDAF) Technical Indicators

Apr 07, 2025, 10:52 AM
Name
Value
Implied Action
RSI (14)
43.09
Neutral
STOCH (9,6)
>-0.01
Buy
STOCHRSI (14)
72.22
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
9.03
Buy
Williams %R
8.33
Sell
CCI (14)
47.62
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
96.00
Buy
ROC
0.00
Buy
Zelira Therapeutics’s (ZLDAF) Relative Strength Index (RSI) is 43.09, creating a Neutral signal.
Zelira Therapeutics’s (ZLDAF) Trend Strength Indicator (ADX) is 9.03, creating a Buy signal.
Zelira Therapeutics’s (ZLDAF) Commodity Channel Index (CCI) is 47.62, creating a Neutral signal.

FAQ

Is ZLDAF a Buy, Hold, or Sell?
Based on ZLDAF’s technical indicators, ZLDAF is a Sell.
    What is ZLDAF’s RSI (14)?
    ZLDAF’s RSI (14) is 43.09, which suggests ZLDAF is a Neutral.
      What is ZLDAF’s MACD?
      ZLDAF’s MACD is >-0.01, which suggests ZLDAF is a Sell.
        What is ZLDAF’s 5-day moving average?
        ZLDAF’s 5-day moving average is 0.30, which suggests ZLDAF is a Buy.
          What is ZLDAF’s 20-day moving average?
          ZLDAF 20-day moving average is 0.30, which suggests ZLDAF is a Buy.
            What is ZLDAF’s 50-day moving average?
            ZLDAF’s 50-day moving average is 0.31, which suggests ZLDAF is a Sell.
              What is ZLDAF’s 200-day moving average?
              ZLDAF’s 200-day moving average is 0.40, which suggests ZLDAF is a Sell.
                What is ZLDAF’s Williams % R (14)?
                ZLDAF’s Williams % R (14) is 8.33, which suggests ZLDAF is a Sell.
                  What is ZLDAF’s CCI (14)?
                  ZLDAF’s CCI (14) is 47.62, which suggests ZLDAF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis